TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background

BASIL, Switzerland—Lonza has announced that the company is investing $93 million in its Capsule and Health Ingredients division to expand production of the division’s Capsugel capsule portfolio by 30 billion capsules per year. The expansion is designed to meet rising demand for the division’s gelatin, vegetarian, specialty polymers, and liquid-filled hard capsules and represents a 15 percent capacity increase. The two-year investment will occur across the company’s global manufacturing and supply chain network, including manufacturing sites in the US, Belgium, France, India, Indonesia, Mexico, Japan, and China.